Research Progress on Bisphenol S-Induced Metabolic Disorder-Related Diseases
Bisphenol S (BPS), a substitute for bisphenol A (BPA), is widely used in food packaging, plastics, and dental fillings. BPS enters and accumulates in the human body via respiratory, digestive, and dermal routes, posing increasing health risks. Epidemiological and animal studies link BPS exposure to metabolic disorders. This review systematically summarizes BPS pollution status and its mechanisms in obesity, non-alcoholic fatty liver disease, diabetes, cardiovascular diseases, and immune system disorders. BPS detection rates reach 78.5% in food samples (up to 67.1 μg·kg−1) and 81.67% in fish (up to 65.31 μg·kg−1). In indoor dust, BPS levels reach 26.6 μg·g−1, with adult daily exposure estimated at 0.78 ng·kg−1 in China. Mechanistically, BPS disrupts lipid and glucose metabolism, induces oxidative stress and inflammation, and alters nuclear receptor signaling. The review highlights the need for molecular target identification and metabolic network interaction studies to develop intervention strategies.